Anagram Therapeutics, Inc.

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements and collaborations between companies and academic or other research inst

Biopharma start-up fundraising more than doubled to $3.87bn in the second quarter versus the prior quarter, helped by initial public offerings, including the Actelion Pharmaceuticals Ltd. spinout